Nika Pharmaceuticals NIKA
OTC NIKA
$0.35 +0.00 (+0.00%)
At close: Nov 6, 2026 · 4:00 PM EST

Nika Pharmaceuticals (NIKA) EBIT (2021 - 2023)

Updated

Nika Pharmaceuticals (NIKA) reported EBIT of -$10,143 for Q3 2023, compared with -$6,339 a year earlier.

Analysis

Nika Pharmaceuticals (NIKA) EBIT (2021 - 2023) Analysis & Trends

Over the twelve months ended Sep 30, 2023, Nika Pharmaceuticals' EBIT came in at -$33,429; for FY2022, it came in at -$3.18 million.

  • By year, EBIT came in at -$14,712 in FY2021.
  • Five-year quarterly EBIT spans a low of -$3.16 million in Q2 2022 and a high of $19,570 in Q1 2023.
  • Per Business Quant data, the three quarters before Q3 2023 came in at -$27,806 (Q2 2023), $19,570 (Q1 2023) and -$15,050 (Q4 2022).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 -10,143.00
Jun 30, 2023 -27,806.00
Mar 31, 2023 19,570.00
Dec 31, 2022 -15,050.00
Sep 30, 2022 -6,339.00
Jun 30, 2022 -3.16 Mn
Mar 31, 2022 6,316.00
Dec 31, 2021 -3,300.00
Sep 30, 2021 -2,699.00
Jun 30, 2021 -2,959.00
Mar 31, 2021 -5,754.00
API Access

Nika Pharmaceuticals EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=NIKA&period=max&api_key=YOUR_API_KEY